IONIS PHARMACEUTICALS INC (IONS)

↓ Download CSV

CIK 0000874015 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated CA
  • Fiscal year ends Dec 31

In fiscal 2025, IONIS PHARMACEUTICALS INC reported revenue of $943.71M, up 33.8% from the prior year. The company ran a net loss, with a net margin of -40.4%. It held $3.52B in total assets against $3.03B in total liabilities.

Key ratios (FY2025)

-40.4%
Operating margin
-40.4%
Net margin
-78.0%
Return on equity
+33.8%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$943.71M$705.14M$787.65M$587.37M$810.46M$729.26M$1.12B$599.67M$514.18M$372.78M
Cost of Revenue$15.91M$11.21M$9.13M$14.12M$10.84M$11.95M$4.38M$1.82M$0$0
Operating Income-$381.68M-$475.08M-$353.73M-$410.19M-$30.19M-$172.08M$365.88M-$61.37M$31.05M-$20.16M
Net Income-$381.39M-$453.90M-$366.29M-$269.72M-$28.60M-$444.26M$278.14M$273.74M$346.0K-$60.40M
EPS (Diluted)$-2.38$-3.04$-2.56$-1.90$-0.20$-3.18$1.90$2.07$0.15$-0.50
Total Assets$3.52B$3.00B$2.99B$2.53B$2.61B$2.39B$3.23B$2.67B$1.32B$912.47M
Total Liabilities$3.03B$2.42B$2.60B$1.96B$1.84B$1.65B$1.55B$1.48B$957.49M$812.90M
Shareholders' Equity$489.09M$588.35M$386.69M$572.89M$771.74M$743.28M$1.47B$1.05B$281.01M$99.56M
Cash & Equivalents$372.26M$242.08M$399.27M$276.47M$869.19M$397.66M$683.29M$278.82M$129.63M$84.69M
Operating Cash Flow-$268.58M-$500.95M-$307.51M-$274.37M$30.80M$35.89M$345.63M$602.91M$174.15M-$112.11M
Capital Expenditures$51.44M$45.28M$23.80M$15.72M$11.96M$35.12M$30.91M$13.61M$34.76M$7.11M
Shares Outstanding163.30M157.91M144.34M142.06M141.21M140.37M140.34M137.93M124.98M121.64M